Our current study has clarified the in vivo role of airway epithelial NF-κB activation in host defense against Mp infection by administrating a non-antimicrobial tetracycline analog 9-TB in conditional NF-κB transgenic mice. The gene discussed is NFKB1; the disease is tuberculosis.